ClinicalTrials.gg
Active, not recruitingNCT07041294Updated Jul 8, 2025

Comparing 7 mm and 5 mm Implants Placed Immediately After Molar Extraction

An interventional study of 7 mm Diameter Dental Implant and 5 mm Diameter Dental Implant in Partial Edentulism in the Maxilla or in the Mandible and Immediate Implant Placement, sponsored by Marco Esposito. Active, not recruiting at 1 site in Albania. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-07-08.

Sponsored by Marco Esposito · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years 8 months after the study started (first participant enrolled Oct 2021, registered Jun 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This clinical study aims to evaluate the performance and long-term outcomes of immediate dental implants placed in molar sites after tooth extraction. Eligible patients will receive one implant and a single crown in a posterior area (first or second molar). The study will compare implant and crown success over a five-year period, tracking complications, bone changes, aesthetics, and patient satisfaction. Participants must be at least 18 years old and have sufficient bone to allow immediate implant placement. This research will provide important data on the safety and reliability of immediate implants in posterior areas.

Read the detailed description

This multicentre randomised controlled trial aims to compare the clinical outcomes of 7 mm versus 5 mm diameter dental implants placed immediately after tooth extraction in the molar region. The goal is to assess whether wider diameter implants offer any advantages in terms of implant survival, complications, bone preservation, and patient satisfaction, when placed in fresh extraction sockets.

A total of 70 patients requiring molar tooth extraction and immediate implant placement will be enrolled across 7 centers. Each participant will receive either a 5 mm or a 7 mm diameter implant, allocated randomly. Standardised surgical and prosthetic protocols will be followed.

Follow-up visits will assess implant stability, radiographic bone changes, and clinical outcomes over time. Patient-reported outcomes and complications will also be recorded to compare the two groups. Results will be reported at 1 and 5 years after loading.

This study may help clinicians make evidence-based decisions when choosing the diameter of implants in molar regions, particularly in immediate post-extraction situations.

02

Conditions studied

  • Partial Edentulism in the Maxilla or in the Mandible
  • Immediate Implant Placement

Keywords

  • Deantal implant
  • Immediate implant
  • Post-extraction implant
  • Wide diameter implant
  • Follow-up
03

In context

Lead sponsor

Marco Esposito is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • at least 18 years old
  • able to sign an form
  • requiring at least one immediate post-extractive implant in first and/or second molar sites
  • sufficient bone to allow placement of an immediate implant at least 7 mm in length and 7 mm in diameter

Exclusion criteria

Exclusion Criteria:

  • general to implant surgery
  • or immunocompromised
  • irradiation in the head or neck area
  • uncontrolled diabetes
  • pregnancy or lactation
  • untreated periodontitis
  • poor oral hygiene and motivation
  • addiction to alcohol or drugs
  • psychiatric disorders
  • unrealistic expectations
  • acute infection (abscess) in the site intended for implant placement
  • necessity to lift the maxillary sinus epithelium
  • unable to commit to 5-year follow-up post-loading
  • under treatment or had previous treatment with intravenous amino-bisphosphonates
  • lack of bony wall completely surrounding the future implant
  • participation in other studies interfering with present protocol.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    7 mm Diameter Implant

    Participants receive a 7 mm diameter implant placed immediately after molar extraction.

    Device: 7 mm Diameter Dental Implant

  • Active comparator
    5 mm Diameter Implant

    Participants receive a 5 mm diameter implant placed immediately after molar extraction.

    Device: 5 mm Diameter Dental Implant

Interventions

  • Device7 mm Diameter Dental Implant

    To evaluate immediate post-extraction implants with different diameters (7 vs. 5 mm)

  • Device5 mm Diameter Dental Implant

    To evaluate immediate post-extraction implants with different diameters (5 vs. 7 mm)

06

What researchers measure

Primary outcomes

  1. Number of failed crowns (not placed or remade due to implant/prosthetic failure)

    whether it will not be possible to place the crown because of implant failure or secondary to implant failure, or crown that has to be remade for any reason.

    Time frame: From implant placement to 5 years after loading.

  2. Number of failed implants (implant mobility, infection, or mechanical complications)

    Implant failure is defined as implant mobility and/or any infection dictating implant removal, and or/any mechanical problems rendering the implant unusable. The stability of each individual implant will be measured by the independent and blinded outcome assessor manually with a reverse torque of 20 Ncm at abutment connection and at delivery of the definitive crown, or by assessing the stability of the crown, using the handles of two metallic instruments, at 1 and 5 years after loading.

    Time frame: From implant placement to 5 years post loading.

  3. Biological and biomechanical complications

    Biological and biomechanical complications will be recorded and reported by study group. Examples of biological complications are: fistula, peri-implantitis. Examples of biomechanical complications are fracture of the metal screws, loosening of the crown, fracture of ceramic.

    Time frame: From implant placement to 5 years after loading.

Secondary outcomes

  1. Peri-implant marginal bone level changes

    Digital intraoral periapical radiographs will be made with the paralleling technique at implant placement, implant loading, 1 and 5 years after loading. In case of unreadable radiograph, the radiograph has to be made again. Radiographs will be converted to TIFF format with a 600 dpi resolution, and stored in a personal computer. Peri-implant marginal bone levels will be measured using the Scion Image (Scion Corporation, Frederick, MD, USA) software. The software will be calibrated for every single image using the known implant length or the diameter of the implant collar. Measurements of the mesial and distal bone crest level adjacent to each implant will be made to the nearest 0.01 mm. Reference points for the linear measurements will be: the coronal margin of the implant collar and the most coronal point of bone-to-implant contact. Bone levels will be measured at both mesial and distal sides and averaged. Bone level at single implants will b

    Time frame: From implant placement to 5 years after loading.

  2. Aesthetic evaluation

    Aesthetic evaluation of the clinical pictures, taken at delivery of the final restorations, 1 and 5 years follow-ups, on a computer screen by an independent blinded dentist. The pictures of the vestibular and occlusal aspects have to include the 2 adjacent teeth, when present. The aesthetic evaluation will be done following the pink aesthetic score(1).

    Time frame: From implant placement to 5 years after loading.

  3. Patient satisfaction

    At the delivery of the final restorations, 1 and 5 years follow-up the independent outcome assessor at each centre will ask to the patient the following questions: 1. Are you satisfied with the function of your implant supported tooth? Possible answers: yes absolutely, yes partly, not sure, not really, absolutely not. 2. Are you satisfied with the aesthetic outcome of your implant supported tooth? Possible answers: yes absolutely, yes partly, not sure, not really, absolutely not. 3. Would you undergo the same therapy again? Possible answers: "yes" or "no".

    Time frame: From implant placement to 5 years after loading.

07

Study locations

1 site
  • Nobel dental clinic
    Tirana, Albania
08

References and documents

Publications

  • Furhauser R, Florescu D, Benesch T, Haas R, Mailath G, Watzek G. Evaluation of soft tissue around single-tooth implant crowns: the pink esthetic score. Clin Oral Implants Res. 2005 Dec;16(6):639-44. doi: 10.1111/j.1600-0501.2005.01193.x. PubMed 16307569 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 8, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07041294
Lead sponsor
Marco Esposito
Responsible party
Marco Esposito (Associate Professor, Marco Esposito) — Sponsor-investigator
First posted
Jun 27, 2025
Start date
Oct 1, 2021
Primary completion
May 15, 2025
Completion
Jun 1, 2029 (estimated)
Last update
Jul 8, 2025

Study contacts

Marco Esposito, Dentistry
principal investigator · IRCCS San Raffaele Scientific Institute and Vita-Salute San Raffaele University, Milan, Italy

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion